Root Financial Partners
CORT icon

Root Financial Partners’s Corcept Therapeutics CORT Stock Holding History

Root Financial Partners’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84.7K Buy
+735
New +$79K ﹤0.01% 820
2026
Q2 		– Sell
-2
Closed -$81 – 994
2026
Q1 		$81 Sell
2
-162
-99% -$6.06K ﹤0.01% 3314
2025
Q4 		$5.71K Sell
164
-38
-19% -$2.98K ﹤0.01% 1722
2025
Q3 		$16.8K Buy
+202
New +$14.6K ﹤0.01% 1205

Other funds holding CORT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Root Financial Partners's CORT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 735 shares worth $84.7K. The stake represents ﹤0.01% of the portfolio and ranks #820 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in CORT as recently as Q1 2026.

Root Financial Partners first reported a position in CORT in Q3 2025 and has held it in 4 quarters since. 403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Root Financial Partners held 735 shares of Corcept Therapeutics worth $84.7K as of Q3 2026.
  • Corcept Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #820 holding.
  • Root Financial Partners first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.